78 related articles for article (PubMed ID: 30642312)
1. Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer.
Schmedt N; Heuer OD; Häckl D; Sato R; Theilacker C
BMC Health Serv Res; 2019 Jan; 19(1):30. PubMed ID: 30642312
[TBL] [Abstract][Full Text] [Related]
2. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.
Sato R; Gomez Rey G; Nelson S; Pinsky B
Appl Health Econ Health Policy; 2013 Jun; 11(3):251-8. PubMed ID: 23605251
[TBL] [Abstract][Full Text] [Related]
3. Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults.
Polsky D; Bonafede M; Suaya JA
BMC Health Serv Res; 2012 Oct; 12():379. PubMed ID: 23113880
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database.
Huang L; Heuer OD; Janßen S; Häckl D; Schmedt N
PLoS One; 2020; 15(1):e0228020. PubMed ID: 31990941
[TBL] [Abstract][Full Text] [Related]
5. The association between influenza immunization coverage rates and hospitalization for community-acquired pneumonia in Alberta.
Jin Y; Carriere KC; Predy G; Johnson DH; Marrie TJ
Can J Public Health; 2003; 94(5):341-5. PubMed ID: 14577740
[TBL] [Abstract][Full Text] [Related]
6. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality.
Ewig S; Birkner N; Strauss R; Schaefer E; Pauletzki J; Bischoff H; Schraeder P; Welte T; Hoeffken G
Thorax; 2009 Dec; 64(12):1062-9. PubMed ID: 19454409
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for hospital admission in the 28 days following a community-acquired pneumonia diagnosis in older adults, and their contribution to increasing hospitalisation rates over time: a cohort study.
Millett ER; De Stavola BL; Quint JK; Smeeth L; Thomas SL
BMJ Open; 2015 Dec; 5(12):e008737. PubMed ID: 26631055
[TBL] [Abstract][Full Text] [Related]
8. Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review.
Tsoumani E; Carter JA; Salomonsson S; Stephens JM; Bencina G
Expert Rev Vaccines; 2023; 22(1):876-884. PubMed ID: 37823894
[TBL] [Abstract][Full Text] [Related]
9. Health promotion, risk stratification, and treatment options to decrease hospitalization rates for community-acquired pneumonia in adults.
Severson C; Renstrom C; Fitzhugh M
J Am Assoc Nurse Pract; 2014 Oct; 26(10):537-49. PubMed ID: 24170698
[TBL] [Abstract][Full Text] [Related]
10. COVID-19-associated costs and mortality in Germany: an incidence-based analysis from a payer's perspective.
Brandt F; Simone G; Loth J; Schilling D
BMC Health Serv Res; 2024 Mar; 24(1):321. PubMed ID: 38468304
[TBL] [Abstract][Full Text] [Related]
11. Direct costs of neonatal infection acquired in the community in full-term newborns and low risk at birth, Cundinamarca, Colombia.
Agudelo SI; Molina CF; Gamboa ÓA; Suárez JD
Biomedica; 2021 Mar; 41(1):87-98. PubMed ID: 33761192
[TBL] [Abstract][Full Text] [Related]
12. [Clinical courses and costs for hospitalizations of potentially immunocompromised COVID-19 patients in Germany].
Häckl D; Pignot M; Dang PL; Lauenroth V; Jah F; Wendtner CM
Dtsch Med Wochenschr; 2024 Mar; 149(7):e38-e46. PubMed ID: 38479416
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Appropriateness of Piperacillin-Tazobactam Prescription in Community-Acquired Pneumonia: A Tertiary-Center Experience.
Almajid A; Bazroon A; Albarbari H; Al-Awami HM; AlAhmed A; Bakhurji OM; Alharbi G; Aldawood F; AlKhamis Z; Alqarni M; Alabdullah M; Almutairi R
Cureus; 2023 Dec; 15(12):e51385. PubMed ID: 38292950
[TBL] [Abstract][Full Text] [Related]
14. High-dimensional phenotyping of the peripheral immune response in community-acquired pneumonia.
Reijnders TDY; Schuurman AR; Verhoeff J; van den Braber M; Douma RA; Faber DR; Paul AGA; Wiersinga WJ; Saris A; Garcia Vallejo JJ; van der Poll T
Front Immunol; 2023; 14():1260283. PubMed ID: 38077404
[TBL] [Abstract][Full Text] [Related]
15. Poor Social Functioning: A Potentially Modifiable Risk Factor for Pneumonia in the Elderly.
Hamaguchi S; Sasaki S; Shimizu S; Yamazaki H; Yamamoto R; Ozaka A; Nakagawa H; Takeshima T; Green J; Fukuhara S
Cureus; 2023 Oct; 15(10):e47520. PubMed ID: 37877109
[TBL] [Abstract][Full Text] [Related]
16. Development of a Predictive Score to Discriminate Community Acquired Pneumonia with Underlying Lung Cancer: A Retrospective Case - Control Study.
Barbosa-Martins J; Mendonça J; Carvalho N; Carvalho C; Soutinho G; Sarmento H; Coutinho C; Cotter J
Respir Med; 2024 May; ():107675. PubMed ID: 38782137
[TBL] [Abstract][Full Text] [Related]
17. Application of vibration response imaging technology in patients with community-acquired pneumonia before and after the treatment.
Jiang H; Chen J; Cao J; Mu L; Hu Z; He J
Exp Ther Med; 2017 Jun; 13(6):3433-3437. PubMed ID: 28587422
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Simultaneous Inoculations of Pneumococcal and Influenza Vaccines in Patients with Coronary Artery Disease.
Shimada K; Morinaga H; Kiyanagi T; Miyazaki T; Nishitani-Yokoyama M; Okai I; Tamura H; Konishi H; Kurata T; Miyauchi K; Daida H
J Atheroscler Thromb; 2021 Aug; 28(8):826-834. PubMed ID: 33055462
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired bacterial pneumonia in adults: An update.
Eshwara VK; Mukhopadhyay C; Rello J
Indian J Med Res; 2020 Apr; 151(4):287-302. PubMed ID: 32461392
[TBL] [Abstract][Full Text] [Related]
20. Burden of Community-Acquired Pneumonia and Unmet Clinical Needs.
Ferreira-Coimbra J; Sarda C; Rello J
Adv Ther; 2020 Apr; 37(4):1302-1318. PubMed ID: 32072494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
